United States Recombinant Hepatitis B Vaccine Market Report 2016

Publisher Name :
Date: 13-Oct-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Recombinant Hepatitis B Vaccine

Revenue, means the sales value of Recombinant Hepatitis B Vaccine

This report studies sales (consumption) of Recombinant Hepatitis B Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- GlaxoSmithKline

- Merck & Co

- Beijing Tiantan Biological

- China National Biotec Group

- Dalian Hissen Bio-pharm

- Hualan

- North China Pharmaceutical Group Corporation

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Hepatitis B Vaccine in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Recombinant Hepatitis B Vaccine Market Report 2016

Table of Contents
United States Recombinant Hepatitis B Vaccine Market Report 2016
1 Recombinant Hepatitis B Vaccine Overview
1.1 Product Overview and Scope of Recombinant Hepatitis B Vaccine
1.2 Classification of Recombinant Hepatitis B Vaccine
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Hepatitis B Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Hepatitis B Vaccine (2011-2021)
1.4.1 United States Recombinant Hepatitis B Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2011-2021)
2 United States Recombinant Hepatitis B Vaccine Competition by Manufacturers
2.1 United States Recombinant Hepatitis B Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Hepatitis B Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Hepatitis B Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Hepatitis B Vaccine Market Competitive Situation and Trends
2.4.1 Recombinant Hepatitis B Vaccine Market Concentration Rate
2.4.2 Recombinant Hepatitis B Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Recombinant Hepatitis B Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Recombinant Hepatitis B Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Recombinant Hepatitis B Vaccine Price by Type (2011-2016)
3.4 United States Recombinant Hepatitis B Vaccine Sales Growth Rate by Type (2011-2016)
4 United States Recombinant Hepatitis B Vaccine Sales (Volume) by Application (2011-2016)
4.1 United States Recombinant Hepatitis B Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Recombinant Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Recombinant Hepatitis B Vaccine Manufacturers Profiles/Analysis
5.1 GlaxoSmithKline
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 GlaxoSmithKline Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck & Co
5.2.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck & Co Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Beijing Tiantan Biological
5.3.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 China National Biotec Group
5.4.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Dalian Hissen Bio-pharm
5.5.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Hualan
5.6.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Hualan Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 North China Pharmaceutical Group Corporation
5.7.2 Recombinant Hepatitis B Vaccine Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 North China Pharmaceutical Group Corporation Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
6 Recombinant Hepatitis B Vaccine Manufacturing Cost Analysis
6.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Recombinant Hepatitis B Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Recombinant Hepatitis B Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Recombinant Hepatitis B Vaccine Market Forecast (2016-2021)
10.1 United States Recombinant Hepatitis B Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Recombinant Hepatitis B Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Recombinant Hepatitis B Vaccine Sales Forecast by Application (2016-2021)
10.4 Recombinant Hepatitis B Vaccine Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Recombinant Hepatitis B Vaccine
Table Classification of Recombinant Hepatitis B Vaccine
Figure United States Sales Market Share of Recombinant Hepatitis B Vaccine by Type in 2015
Table Application of Recombinant Hepatitis B Vaccine
Figure United States Sales Market Share of Recombinant Hepatitis B Vaccine by Application in 2015
Figure United States Recombinant Hepatitis B Vaccine Sales and Growth Rate (2011-2021)
Figure United States Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2011-2021)
Table United States Recombinant Hepatitis B Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Hepatitis B Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Hepatitis B Vaccine Sales Share by Manufacturers
Figure 2016 Recombinant Hepatitis B Vaccine Sales Share by Manufacturers
Table United States Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers
Table 2016 United States Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers
Table United States Market Recombinant Hepatitis B Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Hepatitis B Vaccine Average Price of Key Manufacturers in 2015
Figure Recombinant Hepatitis B Vaccine Market Share of Top 3 Manufacturers
Figure Recombinant Hepatitis B Vaccine Market Share of Top 5 Manufacturers
Table United States Recombinant Hepatitis B Vaccine Sales by Type (2011-2016)
Table United States Recombinant Hepatitis B Vaccine Sales Share by Type (2011-2016)
Figure United States Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2015
Table United States Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Recombinant Hepatitis B Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Hepatitis B Vaccine by Type (2011-2016)
Table United States Recombinant Hepatitis B Vaccine Price by Type (2011-2016)
Figure United States Recombinant Hepatitis B Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Recombinant Hepatitis B Vaccine Sales by Application (2011-2016)
Table United States Recombinant Hepatitis B Vaccine Sales Market Share by Application (2011-2016)
Figure United States Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2015
Table United States Recombinant Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Recombinant Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Merck & Co Basic Information List
Table Merck & Co Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Beijing Tiantan Biological Basic Information List
Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table China National Biotec Group Basic Information List
Table China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table China National Biotec Group Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Dalian Hissen Bio-pharm Basic Information List
Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Hualan Basic Information List
Table Hualan Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table North China Pharmaceutical Group Corporation Basic Information List
Table North China Pharmaceutical Group Corporation Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table North China Pharmaceutical Group Corporation Recombinant Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine
Figure Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure Recombinant Hepatitis B Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Hepatitis B Vaccine Major Manufacturers in 2015
Table Major Buyers of Recombinant Hepatitis B Vaccine
Table Distributors/Traders List
Figure United States Recombinant Hepatitis B Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Recombinant Hepatitis B Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Recombinant Hepatitis B Vaccine Production Forecast by Type (2016-2021)
Table United States Recombinant Hepatitis B Vaccine Consumption Forecast by Application (2016-2021)
  • Global Ureteral Access Sheath Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-May-2018        Price: US 3480 Onwards        Pages: 103
    This report studies the Ureteral Access Sheath market. The Ureteral Access Sheath is indicated for use in endoscopic procedures to facilitate the passage of endoscopes, urological instruments and for the injection of fluids into the urinary tract. Scope of the Report: This report focuses on the Ureteral Access Sheath in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on......
  • Global Sugar Coated Tablets Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-May-2018        Price: US 3480 Onwards        Pages: 101
    Sugar Coated Tablets are coated with a colored or an uncolored sugar layer. The coating is water soluble and quickly dissolves after swallowing. The sugar-coating protects the encapsulated drug from the environment and provides a barrier to objectionable tablet taste or odor. Scope of the Report: This report focuses on the Sugar Coated Tablets in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report cate......
  • Global Recombinant Trypsin Solution Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-May-2018        Price: US 3480 Onwards        Pages: 106
    Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications. Scope of the Report: This report focuses on the Recombinant Trypsin Solution in global market, especially in North America, Europe, Asia-Pa......
  • Global Pneumatic Compression Devices for Lymphedema Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-May-2018        Price: US 3480 Onwards        Pages: 108
    Lymphedema refers to a type of chronic swelling, or edema, which may occur in the arms, legs, neck, trunk or other body parts and causes severe and debilitating symptoms, including decreased mobility, skin breakdown, pain, increased risk of serious infection and marked psychosocial impairment, resulting in significant negative implications for a patient's health and quality of life. The disease occurs when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid from the arm......
  • India Influenza Vaccines Market Research Report 2018
    Published: 17-May-2018        Price: US 3400 Onwards        Pages: 102
    The global Influenza Vaccines market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. India plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Influenza Vaccines development status and future trend in India, focuses on top players in India, also splits Influenz......
  • China Influenza Vaccines Market Research Report 2018
    Published: 17-May-2018        Price: US 3400 Onwards        Pages: 99
    The global Influenza Vaccines market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Influenza Vaccines development status and future trend in China, focuses on top players in China, also splits Influenz......
  • Korea Decoagulant Market Research Report 2018
    Published: 17-May-2018        Price: US 3400 Onwards        Pages: 109
    The global Decoagulant market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Korea plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Decoagulant development status and future trend in Korea, focuses on top players in Korea, also splits Decoagulant by type an......
  • China Decoagulant Market Research Report 2018
    Published: 17-May-2018        Price: US 3400 Onwards        Pages: 114
    The global Decoagulant market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Decoagulant development status and future trend in China, focuses on top players in China, also splits Decoagulant by type an......
  • United States Human Placental Protein Market Report 2018
    Published: 17-May-2018        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Human Placental Protein market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs